Recruiting Narcolepsy Type 1 Studies in Miami Lakes
About Narcolepsy Type 1 Clinical Trials in Miami Lakes
Narcolepsy type 1 is characterized by excessive daytime sleepiness and sudden loss of muscle tone (cataplexy), caused by loss of hypocretin-producing neurons in the brain. It affects about 1 in 2,000 people. Treatment includes stimulants, sodium oxybate, and newer orexin receptor agonists.
There are currently 1 narcolepsy type 1 clinical trials recruiting participants in Miami Lakes, FL. These studies are seeking a combined 222 participants. Research is being sponsored by Centessa Pharmaceuticals (UK) Limited. Clinical trial participation is free and participants receive study-related medical care at no cost.
Narcolepsy Type 1 Clinical Trials in Miami Lakes — FAQ
Are there narcolepsy type 1 clinical trials in Miami Lakes?
Yes, there are 1 narcolepsy type 1 clinical trials currently recruiting in Miami Lakes, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Miami Lakes?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami Lakes research site will contact you about next steps.
Are clinical trials in Miami Lakes free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami Lakes studies also compensate for your time and travel.
What narcolepsy type 1 treatments are being tested?
The 1 active trials in Miami Lakes are testing new therapies including novel drugs, biologics, and treatment approaches for narcolepsy type 1.
Data updated October 15, 2026 from ClinicalTrials.gov